Persistent Systems invests in Boston based DxNow

19 Dec 2013 Evaluate

Persistent Systems, the global leader in software product and technology services, has invested in DxNow, a privately held Boston company that is developing advanced micro-fluidic and imaging technologies for point-of-care diagnostic solutions. DxNow is the second recipient to receive seed money from the Persistent Venture Fund, an early-stage investment fund announced last month, focused on supporting innovation in areas of Persistent’s expertise and involving social, mobile, analytics and cloud computing (SMAC) technologies.

DxNow products and technologies will be initially applied to infection detection in renal dialysis patients and will subsequently address applications in forensics, male fertility, global health and rapid detection of microbial species in the environment to ensure public health and safety.

Persistent Systems is an OPD specialty company, offering the customers the benefits of offshore delivery. It designs, develops and maintains software systems and solutions, creates new applications and enhances the functionality of the customers’ existing software products. It delivers services across all stages of the product life-cycle, which enables it to work with a wide-range of customers and allows it to develop, enhance and deploy its customers’ software products.

Persistent Systems Share Price

3434.70 24.65 (0.72%)
03-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
TCS 3707.35
Infosys 1405.90
HCL Tech. 1314.60
Wipro 443.95
Tech Mahindra 1245.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.